Nukhet Aykin-Burns
Concepts (353)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mitochondria | 20 | 2024 | 397 | 2.480 |
Why?
| Oxidative Stress | 24 | 2023 | 768 | 1.820 |
Why?
| Osteoclasts | 8 | 2024 | 425 | 1.620 |
Why?
| Sirtuin 3 | 8 | 2024 | 19 | 1.580 |
Why?
| Antioxidants | 6 | 2023 | 248 | 0.900 |
Why?
| Bone Resorption | 5 | 2024 | 304 | 0.840 |
Why?
| Polychlorinated Biphenyls | 2 | 2013 | 25 | 0.800 |
Why?
| Reactive Oxygen Species | 9 | 2016 | 408 | 0.790 |
Why?
| Cosmic Radiation | 1 | 2021 | 31 | 0.780 |
Why?
| Tocotrienols | 2 | 2019 | 37 | 0.770 |
Why?
| Radiation-Protective Agents | 2 | 2019 | 74 | 0.740 |
Why?
| Cell Compartmentation | 1 | 2020 | 10 | 0.730 |
Why?
| Osteogenesis | 3 | 2021 | 351 | 0.720 |
Why?
| Green Fluorescent Proteins | 1 | 2020 | 90 | 0.710 |
Why?
| Aging | 5 | 2024 | 688 | 0.640 |
Why?
| Animals | 37 | 2024 | 13150 | 0.640 |
Why?
| Vitamin E | 1 | 2019 | 81 | 0.620 |
Why?
| Superoxide Dismutase | 9 | 2023 | 113 | 0.600 |
Why?
| Mice | 24 | 2024 | 5720 | 0.580 |
Why?
| Linear Energy Transfer | 2 | 2013 | 14 | 0.490 |
Why?
| Neoplasms | 3 | 2023 | 1233 | 0.480 |
Why?
| Keratinocytes | 2 | 2013 | 89 | 0.470 |
Why?
| Cystine | 2 | 2020 | 11 | 0.450 |
Why?
| Radiation Tolerance | 3 | 2013 | 84 | 0.450 |
Why?
| Cell Proliferation | 5 | 2014 | 1007 | 0.440 |
Why?
| Air Pollutants | 1 | 2013 | 61 | 0.430 |
Why?
| Prostate | 1 | 2013 | 117 | 0.430 |
Why?
| Radiation, Ionizing | 5 | 2022 | 100 | 0.420 |
Why?
| Environmental Pollutants | 2 | 2013 | 91 | 0.420 |
Why?
| Acetylcysteine | 5 | 2016 | 100 | 0.410 |
Why?
| Epithelial Cells | 1 | 2013 | 209 | 0.400 |
Why?
| Environmental Exposure | 1 | 2013 | 200 | 0.400 |
Why?
| Deoxyglucose | 5 | 2010 | 36 | 0.390 |
Why?
| Oxygen | 3 | 2011 | 325 | 0.370 |
Why?
| Iron | 3 | 2022 | 122 | 0.360 |
Why?
| Cell Movement | 1 | 2011 | 247 | 0.350 |
Why?
| Hydrogen Peroxide | 4 | 2020 | 114 | 0.340 |
Why?
| Glutathione | 12 | 2016 | 295 | 0.330 |
Why?
| PC12 Cells | 2 | 2006 | 24 | 0.330 |
Why?
| Fibroblasts | 6 | 2016 | 343 | 0.330 |
Why?
| Cell Line, Tumor | 9 | 2020 | 1402 | 0.320 |
Why?
| Membrane Proteins | 1 | 2010 | 342 | 0.310 |
Why?
| Mitochondrial Proteins | 2 | 2024 | 90 | 0.310 |
Why?
| Antineoplastic Agents | 4 | 2023 | 1172 | 0.310 |
Why?
| Apoptosis | 7 | 2020 | 1100 | 0.290 |
Why?
| Male | 18 | 2024 | 25093 | 0.280 |
Why?
| Organoselenium Compounds | 1 | 2006 | 2 | 0.270 |
Why?
| Mice, Knockout | 8 | 2024 | 841 | 0.270 |
Why?
| Organometallic Compounds | 1 | 2006 | 44 | 0.260 |
Why?
| Lead | 1 | 2005 | 33 | 0.250 |
Why?
| Superoxides | 4 | 2013 | 46 | 0.250 |
Why?
| Cricetinae | 5 | 2021 | 192 | 0.250 |
Why?
| Cell Survival | 7 | 2015 | 598 | 0.250 |
Why?
| Mutation | 1 | 2010 | 1293 | 0.240 |
Why?
| Dose-Response Relationship, Drug | 5 | 2015 | 1374 | 0.230 |
Why?
| Osteoporosis | 2 | 2024 | 146 | 0.230 |
Why?
| Animals, Wild | 1 | 2023 | 8 | 0.220 |
Why?
| Fertility Preservation | 1 | 2023 | 8 | 0.220 |
Why?
| Oxidation-Reduction | 4 | 2020 | 319 | 0.220 |
Why?
| Glutathione Disulfide | 6 | 2011 | 41 | 0.210 |
Why?
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2020 | 55 | 0.210 |
Why?
| Adenosine Triphosphate | 3 | 2020 | 234 | 0.210 |
Why?
| Cells, Cultured | 5 | 2020 | 1571 | 0.210 |
Why?
| Receptors, Transferrin | 1 | 2022 | 16 | 0.210 |
Why?
| Oxidative Phosphorylation | 2 | 2020 | 39 | 0.210 |
Why?
| Rats | 8 | 2021 | 3300 | 0.200 |
Why?
| Estrogens | 2 | 2021 | 227 | 0.200 |
Why?
| Carrier Proteins | 2 | 2014 | 304 | 0.200 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 193 | 0.200 |
Why?
| Female | 16 | 2024 | 26329 | 0.200 |
Why?
| Catalase | 7 | 2016 | 67 | 0.200 |
Why?
| Protein C | 1 | 2021 | 18 | 0.190 |
Why?
| Humans | 25 | 2023 | 49827 | 0.190 |
Why?
| Mice, Inbred C57BL | 7 | 2024 | 1806 | 0.190 |
Why?
| Mice, Inbred BALB C | 1 | 2021 | 303 | 0.190 |
Why?
| Hippocampus | 1 | 2023 | 228 | 0.190 |
Why?
| Monocyte-Macrophage Precursor Cells | 1 | 2020 | 7 | 0.180 |
Why?
| Cell Line | 5 | 2015 | 1002 | 0.180 |
Why?
| Subcellular Fractions | 1 | 2020 | 34 | 0.180 |
Why?
| Transduction, Genetic | 1 | 2020 | 45 | 0.180 |
Why?
| Intestine, Small | 1 | 2021 | 109 | 0.180 |
Why?
| Cricetulus | 3 | 2010 | 97 | 0.180 |
Why?
| Biosensing Techniques | 1 | 2020 | 25 | 0.180 |
Why?
| Cysteine | 1 | 2020 | 49 | 0.180 |
Why?
| Cytosol | 1 | 2020 | 82 | 0.180 |
Why?
| Cognition | 1 | 2023 | 336 | 0.180 |
Why?
| Neoplasms, Experimental | 1 | 2020 | 114 | 0.180 |
Why?
| Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 76 | 0.180 |
Why?
| Cell Transformation, Neoplastic | 2 | 2011 | 177 | 0.170 |
Why?
| Microscopy, Fluorescence | 1 | 2020 | 162 | 0.170 |
Why?
| Image Processing, Computer-Assisted | 1 | 2020 | 241 | 0.160 |
Why?
| Disease Models, Animal | 2 | 2023 | 1451 | 0.160 |
Why?
| Myeloid Cells | 1 | 2018 | 39 | 0.160 |
Why?
| Time Factors | 6 | 2016 | 2912 | 0.160 |
Why?
| Cation Transport Proteins | 1 | 2018 | 27 | 0.160 |
Why?
| Skin | 1 | 2021 | 407 | 0.150 |
Why?
| Tumor Suppressor Protein p53 | 2 | 2011 | 202 | 0.150 |
Why?
| Breast Neoplasms | 4 | 2014 | 1169 | 0.150 |
Why?
| Models, Biological | 5 | 2014 | 728 | 0.150 |
Why?
| MicroRNAs | 1 | 2021 | 354 | 0.150 |
Why?
| Buthionine Sulfoximine | 4 | 2016 | 14 | 0.150 |
Why?
| Peroxynitrous Acid | 2 | 2014 | 32 | 0.140 |
Why?
| Malondialdehyde | 3 | 2006 | 51 | 0.140 |
Why?
| Gene Deletion | 1 | 2018 | 266 | 0.140 |
Why?
| Heart | 2 | 2021 | 326 | 0.140 |
Why?
| Radiation Injuries, Experimental | 2 | 2015 | 81 | 0.140 |
Why?
| Genetic Therapy | 2 | 2007 | 114 | 0.140 |
Why?
| bcl-2-Associated X Protein | 2 | 2014 | 56 | 0.140 |
Why?
| Epigenesis, Genetic | 2 | 2020 | 373 | 0.140 |
Why?
| RNA, Messenger | 3 | 2015 | 1105 | 0.140 |
Why?
| Thrombomodulin | 1 | 2016 | 27 | 0.140 |
Why?
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2016 | 22 | 0.140 |
Why?
| Whole-Body Irradiation | 2 | 2015 | 131 | 0.140 |
Why?
| DNA Breaks, Double-Stranded | 1 | 2016 | 71 | 0.140 |
Why?
| Peptides | 2 | 2014 | 222 | 0.130 |
Why?
| Myoblasts | 1 | 2015 | 18 | 0.130 |
Why?
| Guanidines | 1 | 2015 | 31 | 0.130 |
Why?
| DNA Damage | 3 | 2015 | 301 | 0.130 |
Why?
| Signal Transduction | 5 | 2020 | 1617 | 0.130 |
Why?
| Aniline Compounds | 1 | 2015 | 43 | 0.130 |
Why?
| Particulate Matter | 1 | 2015 | 52 | 0.130 |
Why?
| Intestines | 1 | 2016 | 176 | 0.130 |
Why?
| Enzyme Inhibitors | 2 | 2015 | 391 | 0.120 |
Why?
| Mitochondria, Heart | 1 | 2015 | 35 | 0.120 |
Why?
| Recombinant Proteins | 1 | 2016 | 486 | 0.120 |
Why?
| Sulfonamides | 1 | 2015 | 129 | 0.120 |
Why?
| Analgesics, Non-Narcotic | 1 | 2015 | 116 | 0.120 |
Why?
| Hepatocytes | 1 | 2015 | 181 | 0.120 |
Why?
| Blotting, Western | 6 | 2015 | 602 | 0.120 |
Why?
| Hematopoietic Stem Cells | 1 | 2015 | 184 | 0.120 |
Why?
| beta Catenin | 1 | 2014 | 102 | 0.120 |
Why?
| Wnt Signaling Pathway | 1 | 2014 | 92 | 0.120 |
Why?
| Gene Expression Regulation | 4 | 2021 | 979 | 0.120 |
Why?
| Chromosome Aberrations | 1 | 2015 | 298 | 0.110 |
Why?
| Cytoprotection | 1 | 2013 | 35 | 0.110 |
Why?
| Hydroxylation | 1 | 2013 | 61 | 0.110 |
Why?
| Selenoprotein P | 1 | 2013 | 1 | 0.110 |
Why?
| Biotransformation | 1 | 2013 | 86 | 0.110 |
Why?
| Heavy Ions | 1 | 2013 | 15 | 0.110 |
Why?
| Benzoquinones | 1 | 2013 | 29 | 0.110 |
Why?
| Metabolome | 1 | 2014 | 88 | 0.110 |
Why?
| Thymus Neoplasms | 1 | 2013 | 17 | 0.110 |
Why?
| Cell Respiration | 3 | 2022 | 41 | 0.110 |
Why?
| Neoplasms, Radiation-Induced | 1 | 2013 | 39 | 0.110 |
Why?
| DNA | 1 | 2016 | 545 | 0.110 |
Why?
| Genomic Instability | 2 | 2011 | 92 | 0.110 |
Why?
| Macrophages | 1 | 2015 | 364 | 0.110 |
Why?
| Lymphoma | 1 | 2013 | 65 | 0.110 |
Why?
| Acetaminophen | 1 | 2015 | 282 | 0.110 |
Why?
| Lipid Peroxidation | 3 | 2014 | 100 | 0.100 |
Why?
| Chromatography, High Pressure Liquid | 3 | 2015 | 349 | 0.100 |
Why?
| Rotenone | 2 | 2009 | 14 | 0.100 |
Why?
| Succinate Dehydrogenase | 1 | 2011 | 23 | 0.100 |
Why?
| Liver Cirrhosis | 1 | 2014 | 218 | 0.100 |
Why?
| Antimetabolites | 2 | 2010 | 13 | 0.100 |
Why?
| Sex Characteristics | 1 | 2013 | 190 | 0.100 |
Why?
| Protein Subunits | 1 | 2011 | 77 | 0.100 |
Why?
| Dyskeratosis Congenita | 1 | 2011 | 2 | 0.100 |
Why?
| DNA Methylation | 1 | 2015 | 548 | 0.100 |
Why?
| Immunoblotting | 3 | 2021 | 118 | 0.100 |
Why?
| Myocardium | 1 | 2014 | 429 | 0.100 |
Why?
| Telomerase | 1 | 2011 | 27 | 0.090 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2011 | 67 | 0.090 |
Why?
| Gene Expression | 5 | 2013 | 608 | 0.090 |
Why?
| Electron Transport Complex II | 1 | 2009 | 7 | 0.090 |
Why?
| CHO Cells | 2 | 2009 | 120 | 0.090 |
Why?
| Genes, Tumor Suppressor | 1 | 2010 | 73 | 0.090 |
Why?
| Glutathione Peroxidase | 2 | 2007 | 23 | 0.090 |
Why?
| Adult | 3 | 2021 | 13160 | 0.090 |
Why?
| Aged, 80 and over | 2 | 2021 | 3125 | 0.080 |
Why?
| Kidney | 1 | 2014 | 665 | 0.080 |
Why?
| Wound Healing | 1 | 2011 | 206 | 0.080 |
Why?
| Membrane Potential, Mitochondrial | 3 | 2015 | 38 | 0.080 |
Why?
| Zidovudine | 1 | 2008 | 6 | 0.080 |
Why?
| Werner Syndrome | 1 | 2008 | 15 | 0.080 |
Why?
| Exodeoxyribonucleases | 1 | 2008 | 19 | 0.080 |
Why?
| Stress, Physiological | 1 | 2010 | 170 | 0.080 |
Why?
| RecQ Helicases | 1 | 2008 | 20 | 0.080 |
Why?
| Cell Differentiation | 2 | 2022 | 653 | 0.080 |
Why?
| Sirtuins | 1 | 2008 | 11 | 0.080 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2008 | 13 | 0.080 |
Why?
| Polyethylene Glycols | 3 | 2016 | 96 | 0.080 |
Why?
| Liver | 1 | 2014 | 1109 | 0.080 |
Why?
| Tobacco Smoke Pollution | 1 | 2008 | 48 | 0.080 |
Why?
| Glucose | 2 | 2007 | 340 | 0.080 |
Why?
| Carmustine | 1 | 2007 | 12 | 0.080 |
Why?
| Forkhead Transcription Factors | 1 | 2008 | 112 | 0.080 |
Why?
| Adenoviridae | 1 | 2007 | 51 | 0.080 |
Why?
| Immunohistochemistry | 3 | 2021 | 971 | 0.080 |
Why?
| Colonic Neoplasms | 1 | 2009 | 162 | 0.070 |
Why?
| Antineoplastic Agents, Alkylating | 1 | 2007 | 74 | 0.070 |
Why?
| Antiviral Agents | 2 | 2021 | 174 | 0.070 |
Why?
| Radiation-Sensitizing Agents | 1 | 2007 | 53 | 0.070 |
Why?
| Methionine | 1 | 2008 | 135 | 0.070 |
Why?
| Myocytes, Cardiac | 1 | 2008 | 125 | 0.070 |
Why?
| Cisplatin | 1 | 2008 | 278 | 0.070 |
Why?
| Neurites | 1 | 2006 | 14 | 0.070 |
Why?
| Glutamate-Cysteine Ligase | 1 | 2006 | 20 | 0.070 |
Why?
| Caspase 3 | 1 | 2006 | 97 | 0.070 |
Why?
| Protein Kinase C | 1 | 2006 | 71 | 0.070 |
Why?
| Heart Diseases | 1 | 2008 | 208 | 0.070 |
Why?
| Trypan Blue | 1 | 2005 | 6 | 0.070 |
Why?
| Caspases | 1 | 2006 | 104 | 0.060 |
Why?
| Head and Neck Neoplasms | 1 | 2008 | 268 | 0.060 |
Why?
| Drug Combinations | 1 | 2005 | 123 | 0.060 |
Why?
| Pancreatic Neoplasms | 1 | 2007 | 213 | 0.060 |
Why?
| Gene Knockdown Techniques | 2 | 2015 | 106 | 0.060 |
Why?
| Dose-Response Relationship, Radiation | 2 | 2016 | 184 | 0.060 |
Why?
| Transfection | 3 | 2011 | 357 | 0.060 |
Why?
| Acetylation | 1 | 2024 | 99 | 0.060 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2015 | 129 | 0.060 |
Why?
| Protein Kinases | 1 | 2024 | 72 | 0.060 |
Why?
| Prostatic Neoplasms | 1 | 2007 | 396 | 0.060 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2009 | 987 | 0.060 |
Why?
| Middle Aged | 2 | 2021 | 11997 | 0.060 |
Why?
| Aged | 2 | 2021 | 9272 | 0.060 |
Why?
| Ovary | 1 | 2023 | 104 | 0.050 |
Why?
| Reproduction | 1 | 2023 | 61 | 0.050 |
Why?
| Hematopoiesis | 1 | 2022 | 71 | 0.050 |
Why?
| Gene Expression Regulation, Enzymologic | 2 | 2015 | 181 | 0.050 |
Why?
| Phenylketonurias | 1 | 2002 | 10 | 0.050 |
Why?
| Cytoskeleton | 1 | 2022 | 39 | 0.050 |
Why?
| Mice, Transgenic | 2 | 2014 | 555 | 0.050 |
Why?
| Ferrets | 1 | 2021 | 6 | 0.050 |
Why?
| Rats, Sprague-Dawley | 2 | 2016 | 1595 | 0.050 |
Why?
| Young Adult | 1 | 2011 | 3936 | 0.050 |
Why?
| Glycolysis | 1 | 2021 | 70 | 0.050 |
Why?
| NADP | 3 | 2007 | 22 | 0.050 |
Why?
| ROC Curve | 1 | 2021 | 232 | 0.050 |
Why?
| Cell Count | 1 | 2020 | 146 | 0.040 |
Why?
| Mutagenesis, Site-Directed | 2 | 2011 | 99 | 0.040 |
Why?
| Genotype | 1 | 2021 | 538 | 0.040 |
Why?
| Heart Rate | 1 | 2021 | 292 | 0.040 |
Why?
| Free Radical Scavengers | 2 | 2010 | 25 | 0.040 |
Why?
| HCT116 Cells | 2 | 2009 | 22 | 0.040 |
Why?
| Protein Binding | 2 | 2013 | 660 | 0.040 |
Why?
| Tumor Microenvironment | 1 | 2020 | 210 | 0.040 |
Why?
| Proteomics | 1 | 2021 | 328 | 0.040 |
Why?
| Sulfhydryl Compounds | 2 | 2008 | 14 | 0.040 |
Why?
| Osteoblasts | 1 | 2021 | 449 | 0.040 |
Why?
| Bone Density | 1 | 2020 | 379 | 0.040 |
Why?
| Flow Cytometry | 2 | 2013 | 470 | 0.040 |
Why?
| Mice, Nude | 2 | 2009 | 252 | 0.040 |
Why?
| Hematopoietic Stem Cell Transplantation | 1 | 2022 | 553 | 0.040 |
Why?
| Antimycin A | 2 | 2009 | 5 | 0.040 |
Why?
| Drug Synergism | 2 | 2009 | 150 | 0.040 |
Why?
| Electron Transport | 2 | 2009 | 25 | 0.040 |
Why?
| Inflammation | 1 | 2021 | 604 | 0.040 |
Why?
| Tumor Cells, Cultured | 2 | 2007 | 465 | 0.040 |
Why?
| Peroxidase | 1 | 2016 | 15 | 0.040 |
Why?
| Glutathione Reductase | 2 | 2007 | 14 | 0.030 |
Why?
| Embryo, Mammalian | 1 | 2016 | 65 | 0.030 |
Why?
| Bone and Bones | 1 | 2020 | 468 | 0.030 |
Why?
| Neutrophil Infiltration | 1 | 2016 | 26 | 0.030 |
Why?
| Primary Cell Culture | 1 | 2016 | 61 | 0.030 |
Why?
| Gamma Rays | 1 | 2016 | 49 | 0.030 |
Why?
| Aldehydes | 1 | 2016 | 83 | 0.030 |
Why?
| Colony-Forming Units Assay | 1 | 2015 | 23 | 0.030 |
Why?
| Rejuvenation | 1 | 2015 | 6 | 0.030 |
Why?
| Ganciclovir | 1 | 2015 | 24 | 0.030 |
Why?
| Nitric Oxide Synthase Type I | 1 | 2015 | 10 | 0.030 |
Why?
| Reactive Nitrogen Species | 1 | 2015 | 22 | 0.030 |
Why?
| DNA, Satellite | 1 | 2015 | 14 | 0.030 |
Why?
| NAD | 1 | 2015 | 43 | 0.030 |
Why?
| Microscopy | 1 | 2015 | 56 | 0.030 |
Why?
| Combined Modality Therapy | 2 | 2007 | 636 | 0.030 |
Why?
| Transforming Growth Factor beta | 1 | 2016 | 144 | 0.030 |
Why?
| bcl-X Protein | 1 | 2015 | 50 | 0.030 |
Why?
| Mitochondria, Liver | 1 | 2015 | 70 | 0.030 |
Why?
| DNA Transposable Elements | 1 | 2015 | 107 | 0.030 |
Why?
| Epigenomics | 1 | 2015 | 67 | 0.030 |
Why?
| X-Rays | 1 | 2015 | 55 | 0.030 |
Why?
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2014 | 6 | 0.030 |
Why?
| Collagen | 1 | 2016 | 206 | 0.030 |
Why?
| Intestinal Mucosa | 1 | 2016 | 225 | 0.030 |
Why?
| B-Lymphocytes | 1 | 2015 | 170 | 0.030 |
Why?
| Oxygen Consumption | 1 | 2015 | 180 | 0.030 |
Why?
| Cell Cycle | 1 | 2015 | 232 | 0.030 |
Why?
| Mitochondrial Membrane Transport Proteins | 1 | 2014 | 18 | 0.030 |
Why?
| NG-Nitroarginine Methyl Ester | 1 | 2014 | 18 | 0.030 |
Why?
| Electron Transport Chain Complex Proteins | 1 | 2014 | 9 | 0.030 |
Why?
| Ubiquinone | 1 | 2014 | 12 | 0.030 |
Why?
| Organophosphorus Compounds | 1 | 2014 | 15 | 0.030 |
Why?
| Thymocytes | 1 | 2013 | 2 | 0.030 |
Why?
| Cesium Radioisotopes | 1 | 2013 | 4 | 0.030 |
Why?
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2013 | 3 | 0.030 |
Why?
| Silicon | 1 | 2013 | 8 | 0.030 |
Why?
| Protein Conformation | 1 | 2014 | 166 | 0.030 |
Why?
| Gene Order | 1 | 2013 | 13 | 0.030 |
Why?
| Mice, Mutant Strains | 1 | 2013 | 71 | 0.030 |
Why?
| Neoplastic Syndromes, Hereditary | 1 | 2013 | 16 | 0.030 |
Why?
| Leukocyte Count | 1 | 2013 | 70 | 0.030 |
Why?
| Gene Targeting | 1 | 2013 | 30 | 0.030 |
Why?
| Gene Dosage | 1 | 2013 | 78 | 0.030 |
Why?
| Metabolomics | 1 | 2014 | 124 | 0.030 |
Why?
| Lipid Metabolism | 1 | 2014 | 175 | 0.030 |
Why?
| DNA, Mitochondrial | 1 | 2014 | 112 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 181 | 0.030 |
Why?
| Recombinant Fusion Proteins | 1 | 2013 | 182 | 0.030 |
Why?
| Radiation Dosage | 1 | 2013 | 157 | 0.030 |
Why?
| Up-Regulation | 1 | 2014 | 450 | 0.030 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 412 | 0.030 |
Why?
| Mutation Rate | 1 | 2011 | 36 | 0.020 |
Why?
| Point Mutation | 1 | 2011 | 65 | 0.020 |
Why?
| Plasmids | 1 | 2011 | 159 | 0.020 |
Why?
| Transglutaminases | 1 | 2010 | 15 | 0.020 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 829 | 0.020 |
Why?
| Tubulin | 1 | 2010 | 22 | 0.020 |
Why?
| Neuroblastoma | 1 | 2010 | 52 | 0.020 |
Why?
| Muscle, Skeletal | 1 | 2015 | 750 | 0.020 |
Why?
| GTP-Binding Proteins | 1 | 2010 | 90 | 0.020 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 103 | 0.020 |
Why?
| Glycoproteins | 1 | 2010 | 115 | 0.020 |
Why?
| Uncoupling Agents | 1 | 2009 | 5 | 0.020 |
Why?
| HT29 Cells | 1 | 2009 | 11 | 0.020 |
Why?
| Polymerase Chain Reaction | 1 | 2011 | 455 | 0.020 |
Why?
| Antigens, CD | 1 | 2010 | 215 | 0.020 |
Why?
| Tumor Burden | 1 | 2009 | 132 | 0.020 |
Why?
| Stem Cells | 1 | 2010 | 171 | 0.020 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2009 | 210 | 0.020 |
Why?
| COS Cells | 1 | 2008 | 75 | 0.020 |
Why?
| Chromatin Immunoprecipitation | 1 | 2008 | 49 | 0.020 |
Why?
| Methionine Sulfoxide Reductases | 1 | 2008 | 2 | 0.020 |
Why?
| Calmodulin | 1 | 2008 | 10 | 0.020 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2008 | 88 | 0.020 |
Why?
| Cell Culture Techniques | 1 | 2008 | 99 | 0.020 |
Why?
| Oxidoreductases | 1 | 2008 | 57 | 0.020 |
Why?
| Tumor Stem Cell Assay | 1 | 2007 | 17 | 0.020 |
Why?
| Transplantation, Heterologous | 1 | 2007 | 74 | 0.020 |
Why?
| Mice, Inbred Strains | 1 | 2007 | 161 | 0.020 |
Why?
| Drug Therapy, Combination | 1 | 2008 | 378 | 0.020 |
Why?
| Down-Regulation | 1 | 2008 | 349 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 595 | 0.020 |
Why?
| Nuclear Proteins | 1 | 2008 | 243 | 0.020 |
Why?
| Angiotensin II | 1 | 2008 | 157 | 0.020 |
Why?
| Neurons | 1 | 2010 | 459 | 0.020 |
Why?
| Neoplasm Proteins | 1 | 2008 | 323 | 0.020 |
Why?
| Calcium | 1 | 2008 | 397 | 0.020 |
Why?
| Antimetabolites, Antineoplastic | 1 | 2006 | 37 | 0.020 |
Why?
| Methacrylates | 1 | 2004 | 6 | 0.020 |
Why?
| Electron Spin Resonance Spectroscopy | 1 | 2004 | 10 | 0.020 |
Why?
| Free Radicals | 1 | 2004 | 28 | 0.020 |
Why?
| Lung | 1 | 2008 | 480 | 0.020 |
Why?
| Cell Line, Transformed | 1 | 2004 | 72 | 0.020 |
Why?
| Electrons | 1 | 2004 | 19 | 0.020 |
Why?
| Oxidants | 1 | 2004 | 53 | 0.020 |
Why?
| Manganese | 1 | 2004 | 23 | 0.020 |
Why?
| Thiazoles | 1 | 2004 | 51 | 0.020 |
Why?
| Osteosarcoma | 1 | 2004 | 47 | 0.010 |
Why?
| Glucosephosphate Dehydrogenase | 1 | 2002 | 6 | 0.010 |
Why?
| Erythrocytes | 1 | 2002 | 79 | 0.010 |
Why?
| Phenylalanine | 1 | 2002 | 128 | 0.010 |
Why?
| Brain | 1 | 2002 | 1309 | 0.010 |
Why?
|
|
Aykin-Burns's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|